Category: Drug Discovery
Drug Discovery market research reports by GlobalData
-
Focal Segmental Glomerulosclerosis: Competitive Landscape
Focal Segmental Glomerulosclerosis: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Focal Segmental Glomerulosclerosis therapeutics. In 2024, more than 36,000 diagnosed incident cases of FSGS are anticipated in the 16 coun ... Read More
-
Acute coronary syndrome: Competitive Landscape
Acute coronary syndrome: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Acute coronary syndrome therapeutics. In 2024, more than 7.8 million hospitalized incident cases of ACS are anticipated in the 16 countries covered i ... Read More
-
Migraine: 68-Market Analysis and Sales Forecast
Migraine: 68-Market Analysis and Sales Forecast Summary GlobalData estimates that the value of the migraine market in the 7MM in 2023 was $9.2 billion. This market is defined as sales of acute and preventative treatments including widely used triptans and ergot alkaloids used in abortive treatment a ... Read More
-
Chronic Urticaria: Competitive Landscape
Chronic Urticaria: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in chronic urticaria therapeutics. In 2024, more than 60 million diagnosed prevalent cases of CU are anticipated in the 16 countries covered in GlobalData’s e ... Read More
-
Thematic Intelligence: The Future of Healthcare
Thematic Intelligence: The Future of Healthcare Summary This report is part of GlobalData's Future of Industry report series. It focuses on the healthcare sector.Several technologies will drive the future of healthcare. They include 3D printing, robotics, preventive medicine, and digital therapeutic ... Read More
-
Clinical Trials: Psychedelic Therapeutics
Clinical Trials: Psychedelic Therapeutics Summary This report provides a review of global psychedelic therapeutic clinical trials derived from the GlobalData’s Clinical Trials Database. The aim of this report is to identify key analyses and segmentations of these trials. As the number of psychedelic ... Read More
-
Prurigo Nodularis: Competitive Landscape
Prurigo Nodularis: Competitive Landscape Prurigo Nodularis: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PN therapeutics. In 2024, more than 1.4 million diagnosed prevalent cases of PN are anticipated in the 16 countrie ... Read More
-
Female Infertility: Seven-Market Drug Forecast and Market Analysis
Female Infertility: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Female infertility market through 2033. GlobalData estimates that the value of the female infertilit ... Read More
-
Female Infertility: Epidemiology Forecast to 2033
Female Infertility: Epidemiology Forecast to 2033 Summary Infertility is a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 or more months of regular unprotected sexual intercourse (Zegers-Hochschild et al., 2009; Mascarenhas et al., 2012; Mayo Clini ... Read More
-
Osteoporosis: Seven-Market Drug Forecast and Market Analysis
Osteoporosis: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Osteoporosis market through 2033. Osteoporosis is defined as a systemic skeletal disease characterized by ... Read More
-
Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis
Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Chronic Kidney Disease (CKD) market through 2033. GlobalData estimates the sales of CKD therapeu ... Read More
-
Niemann Pick Type C: Opportunity Assessment and Forecast - Update
Niemann Pick Type C: Opportunity Assessment and Forecast - Update Summary The prevalence of Niemann Pick Type C (NPC) is increasing at a steady rate, in line with population growth in the 3MM at an AGR of 0.29%. Currently, the treatment regimen for NPC in the 3MM is entirely limited to the use of mi ... Read More
-
MELAS Syndrome: Competitive Landscape
MELAS Syndrome: Competitive Landscape MELAS Syndrome: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in MELAS therapeutics. More than 20,000 diagnosed prevalent cases of MELAS Syndrome are anticipated in 2024 in the 16 count ... Read More
-
Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update
Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan and Canada) and provides an Excel-based forecast model for the Amyotrophic Lateral Sclerosis (ALS) market through 2029. The prevalenc ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Attention Deficit Hyperactivity Disorder (ADHD) market through 2032. The ... Read More
-
Thematic Intelligence: Rare Disease
Thematic Intelligence: Rare Disease Summary In recent years, there has been growing recognition of the importance of rare diseases as a global health priority, leading to increased research efforts, policy initiatives, and collaborative partnerships aimed at accelerating progress in this field. Key ... Read More
-
Post-operative Pain (POP) - Competitive Landscape
Post-operative Pain (POP) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in POP therapeutics. In 2024, more than 34,000,000 incident cases of POP are anticipated in the 16 countries covered in GlobalData’s epidemiology for ... Read More
-
Friedreich Ataxia (FRDA) - Competitive Landscape
Friedreich Ataxia (FRDA) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in FRDA therapeutics. More than 54,000 diagnosed prevalent cases of FRDA are anticipated in 2024 in the 16 countries covered in GlobalData’s epidemiol ... Read More
-
New Prescription - Generative AI meets Healthcare (Vol. 2)
New Prescription - Generative AI meets Healthcare (Vol. 2) Summary GlobalData's latest Innovation Radar report New Prescription: Generative AI Meets Healthcare (Vol. 2), expands upon its predecessor and digs further into the transformative capabilities of generative AI within the pharmaceutical and ... Read More
-
Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs
Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs Summary This comprehensive conversation analysis report delves into the most popular weight loss drugs on Reddit in the last six months (October 1st, 2023, to March 31st, 2024), offering a nuanced understanding of their prominence and po ... Read More
-
Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033
Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033 Summary Methicillin-resistant Staphylococcus aureus (MRSA) is a virulent, antibiotic-resistant bacteria that is associated with considerable morbidity and mortality (Vázquez-Sánchez et al., 2022). MRSA can ... Read More
-
New Drug Approvals and Their Contract Manufacture - 2024 Edition
New Drug Approvals and Their Contract Manufacture - 2024 Edition Summary This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called CMO Sco ... Read More
-
Acne Vulgaris (AV) - Competitive Landscape
Acne Vulgaris (AV) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AV therapeutics. GlobalData epidemiologists estimated more than 403 million diagnosed prevalent cases of AV in 2023 in the 16 countries covered in Global ... Read More
-
Resistant Hypertension (RH) - Competitive Landscape
Resistant Hypertension (RH) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in RH therapeutics. GlobalData epidemiologists estimated more than 79 million diagnosed prevalent cases of RH in 2023 in the 16 countries covered i ... Read More
-
Psychedelics Therapeutics Development and Trends, 2024
Psychedelics Therapeutics Development and Trends, 2024 Summary This report provides a summary of the current and future state of the psychedelic therapeutic sector, offering a high-level analysis of key trends and developments within the industry, including regulatory, clinical, and market dynamics. ... Read More
Research Assistance
